Symmetric vaccine efficacy
Biometrics · 01.07.2026 · 82 (3)
DOI: 10.1093/biomtc/ujag141 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biometrics, online erschienen am 11.08.2026. Verfasst von Lucy D'Agostino McGowan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Statistical Sciences, Wake Forest University, Winston-Salem, NC 27106, United States. Hauptthemen laut MEDLINE: Vaccine Efficacy, Models, Statistical. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Traditional measures of vaccine efficacy (VE) are inherently asymmetric, constrained above by 1 but unbounded below. As a result, VE estimates and corresponding confidence intervals (CIs) can extend far below zero, making interpretation difficult and potentially obscuring whether the apparent effect reflects true harm or simply statistical uncertainty. The proposed symmetric vaccine efficacy (SVE) is a bounded and interpretable alternative to VE that maintains desirable statistical properties while resolving these asymmetries. SVE is defined as a symmetric transformation of infection risks, with possible values within $[-1, 1]$, providing a common scale for both beneficial and harmful vaccine effects. This paper describes the relationship between SVE and traditional VE, considers inference about SVE, and illustrates the utility of the proposed measure by reanalyzing data from a randomized trial of a candidate HIV vaccine. Open-source tools for computing estimates of SVE and corresponding CIs are available in R through the sve package.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Statistical Sciences, Wake Forest University, Winston-Salem, NC 27106, United States.
- Department of Biostatistics University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States.
ORCID-Profile: Lucy D'Agostino McGowan, Sarah C Lotspeich
Förderung
- NIAID NIH HHS
- NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health
Zitieren
APA
D'Agostino McGowan, L., Lotspeich, S. C., & Hudgens, M. G. (2026). Symmetric vaccine efficacy. Biometrics, 82(3). https://doi.org/10.1093/biomtc/ujag141
Vancouver
D'Agostino McGowan L, Lotspeich SC, Hudgens MG. Symmetric vaccine efficacy. Biometrics. 2026;82(3). doi:10.1093/biomtc/ujag141
BibTeX
@article{DAgostinoMcGowan2026,
author = {D'Agostino McGowan, Lucy and Lotspeich, Sarah C and Hudgens, Michael G},
title = {Symmetric vaccine efficacy},
journal = {Biometrics},
year = {2026},
volume = {82},
number = {3},
doi = {10.1093/biomtc/ujag141}
}
EUVIMED